406 related articles for article (PubMed ID: 16423862)
21. Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.
Woolbright BL; Jaeschke H
Methods Mol Biol; 2015; 1250():363-76. PubMed ID: 26272158
[TBL] [Abstract][Full Text] [Related]
22. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis.
Canbay A; Guicciardi ME; Higuchi H; Feldstein A; Bronk SF; Rydzewski R; Taniai M; Gores GJ
J Clin Invest; 2003 Jul; 112(2):152-9. PubMed ID: 12865404
[TBL] [Abstract][Full Text] [Related]
23. Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signaling.
Zhang L; Pan Q; Zhang L; Xia H; Liao J; Zhang X; Zhao N; Xie Q; Liao M; Tan Y; Li Q; Zhu J; Li L; Fan S; Li J; Zhang C; Cai SY; Boyer JL; Chai J
Hepatology; 2023 Jun; 77(6):1866-1881. PubMed ID: 36647589
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice.
Copple BL; Kaska S; Wentling C
J Pharmacol Exp Ther; 2012 May; 341(2):307-16. PubMed ID: 22271822
[TBL] [Abstract][Full Text] [Related]
25. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
Wang H; Zhang Y; Heuckeroth RO
Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells.
Sakai N; Van Sweringen HL; Belizaire RM; Quillin RC; Schuster R; Blanchard J; Burns JM; Tevar AD; Edwards MJ; Lentsch AB
J Gastroenterol Hepatol; 2012 Oct; 27(10):1609-16. PubMed ID: 22646996
[TBL] [Abstract][Full Text] [Related]
27. Characterization of time-related changes after experimental bile duct ligation.
Georgiev P; Jochum W; Heinrich S; Jang JH; Nocito A; Dahm F; Clavien PA
Br J Surg; 2008 May; 95(5):646-56. PubMed ID: 18196571
[TBL] [Abstract][Full Text] [Related]
28. Ethanol-induced liver injury: potential roles for egr-1.
Pritchard MT; Nagy LE
Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):146S-150S. PubMed ID: 16344600
[TBL] [Abstract][Full Text] [Related]
29. The Role of Inflammation in the Mechanisms of Bile Acid-Induced Liver Damage.
Cai SY; Boyer JL
Dig Dis; 2017; 35(3):232-234. PubMed ID: 28249287
[TBL] [Abstract][Full Text] [Related]
30. NF-kappaB is activated in cholestasis and functions to reduce liver injury.
Miyoshi H; Rust C; Guicciardi ME; Gores GJ
Am J Pathol; 2001 Mar; 158(3):967-75. PubMed ID: 11238044
[TBL] [Abstract][Full Text] [Related]
31. Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis.
Cai SY; Yu D; Soroka CJ; Wang J; Boyer JL
J Hepatol; 2021 Mar; 74(3):550-559. PubMed ID: 33039404
[TBL] [Abstract][Full Text] [Related]
32. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
[TBL] [Abstract][Full Text] [Related]
33. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
[TBL] [Abstract][Full Text] [Related]
34. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
35. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
He H; Mennone A; Boyer JL; Cai SY
Hepatology; 2011 Feb; 53(2):548-57. PubMed ID: 21274875
[TBL] [Abstract][Full Text] [Related]
36. [Role of early growth response factor-1 signal pathway in acute intrahepatic cholestatic hepatic injury in rats].
Ding Y; Zhao L; Huang ZH; Mei H; Peng HM
Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):215-9. PubMed ID: 18364083
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of nerve growth factor in cholestatic livers and its hepatoprotective role against oxidative stress.
Tsai MS; Lin YC; Sun CK; Huang SC; Lee PH; Kao YH
PLoS One; 2014; 9(11):e112113. PubMed ID: 25397406
[TBL] [Abstract][Full Text] [Related]
38. Early growth response (EGR)-1 is required for timely cell-cycle entry and progression in hepatocytes after acute carbon tetrachloride exposure in mice.
Pritchard MT; Malinak RN; Nagy LE
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1124-31. PubMed ID: 21415413
[TBL] [Abstract][Full Text] [Related]
39. Activation of necroptosis in human and experimental cholestasis.
Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
[TBL] [Abstract][Full Text] [Related]
40. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
